Data / Drug companies / Nicotinic Acid
Nicotinic Acid drugs: 2 drugs from 31 companies in the FDA NDC directory
Nicotinic Acid is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 72 products in this class from 31 companies, covering 2 drugs by generic name. The main marketing category is other unapproved drugs, and the newest product started marketing on August 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 31Companies
- 72Products
- 2Drugs by generic name
Drugs in the Nicotinic Acid class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Niacin | 24 | 13 |
| Methyl nicotinate, capsaicin | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| PureTek Corporation | 9 | tablet; tablet, chewable | Other unapproved drugs | May 15, 2025 |
| Bryant Ranch Prepack | 7 | tablet, chewable; tablet | Other unapproved drugs | October 1, 2018 |
| Bryant Ranch Prepack | 4 | tablet, chewable; tablet | Other unapproved drugs | October 1, 2018 |
| Guna Spa | 4 | solution/ drops; pellet | Unapproved homeopathic products | December 21, 2018 |
| Method Pharmaceuticals, LLC | 4 | tablet, chewable; tablet | Other unapproved drugs | October 1, 2018 |
| U.S. Pharmaceutical Corporation | 4 | capsule; capsule, liquid filled | Other unapproved drugs | June 24, 2009 |
| Amneal Pharmaceuticals LLC | 3 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | December 11, 2015 |
| Aurobindo Pharma Limited | 3 | tablet, extended release | Generic drugs (ANDA) | February 1, 2018 |
| Nutritional Specialties, Inc. | 3 | spray; liquid | Unapproved homeopathic products | June 5, 2024 |
| Professional Complementary Health Formulas | 3 | liquid | Unapproved homeopathic products | August 15, 1984 |
| Sun Pharmaceutical Industries, Inc. | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | June 27, 2014 |
| Chartwell RX, LLC | 2 | tablet, extended release | Generic drugs (ANDA) | February 16, 2017 |
| Golden State Medical Supply, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | June 16, 2017 |
| Lannett Company, Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | February 16, 2017 |
| Macleods Pharmaceuticals Limited | 2 | tablet | Generic drugs (ANDA) | March 3, 2022 |
| Quagen Pharmaceuticals LLC | 2 | tablet, extended release | Generic drugs (ANDA) | August 6, 2026 |
| Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals | 1 | powder | Other unapproved drugs | March 22, 2024 |
| Apex Energetics Inc. | 1 | solution/ drops | Unapproved homeopathic products | August 15, 1988 |
| AvPAK | 1 | tablet, extended release | Generic drugs (ANDA) | September 14, 2017 |
| Avondale Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | May 3, 2000 |
| BioActive Nutritional, Inc. | 1 | spray | Unapproved homeopathic products | May 4, 2012 |
| Carwin Pharmaceutical Associates, LLC | 1 | capsule, liquid filled | Other unapproved drugs | June 1, 2015 |
| Dna Labs, Inc. | 1 | solution | Unapproved homeopathic products | January 1, 1990 |
| Emerald Therapeutics, LLC | 1 | tablet | Generic drugs (ANDA) | May 3, 2000 |
| Exeltis USA, Inc. | 1 | capsule, gelatin coated | Other unapproved drugs | June 13, 2011 |
| Key 2 Health, Inc. | 1 | cream | Over the counter monograph drugs | February 11, 2011 |
| Lupin Pharmaceuticals, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | March 20, 2014 |
| Oncora Pharma, LLC | 1 | tablet, chewable | Other unapproved drugs | April 7, 2026 |
| Redmont Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | May 3, 2000 |
| Remedyrepack Inc. | 1 | tablet | Other unapproved drugs | November 5, 2022 |
| Strand Health Group | 1 | patch | Over the counter monograph drugs | June 29, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 17 | 23.6% |
| Tablet, extended release | 15 | 20.8% |
| Tablet | 14 | 19.4% |
| Liquid | 4 | 5.6% |
| Solution/ drops | 4 | 5.6% |
| Tablet, film coated, extended release | 4 | 5.6% |
| Capsule | 3 | 4.2% |
| Spray | 3 | 4.2% |
| Capsule, liquid filled | 2 | 2.8% |
| Capsule, gelatin coated | 1 | 1.4% |
| Powder | 1 | 1.4% |
| Pellet | 1 | 1.4% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.